Published in Neuron on March 01, 1998
Initial coupling of binding to gating mediated by conserved residues in the muscle nicotinic receptor. J Gen Physiol (2005) 1.91
Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome. Am J Hum Genet (2002) 1.61
Current status of the congenital myasthenic syndromes. Neuromuscul Disord (2011) 1.60
Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol (2015) 1.44
A quantitative description of KcsA gating II: single-channel currents. J Gen Physiol (2007) 1.41
Mutation causing severe myasthenia reveals functional asymmetry of AChR signature cystine loops in agonist binding and gating. J Clin Invest (2003) 1.36
On the structural basis of modal gating behavior in K(+) channels. Nat Struct Mol Biol (2010) 1.29
Fundamental gating mechanism of nicotinic receptor channel revealed by mutation causing a congenital myasthenic syndrome. J Gen Physiol (2000) 1.18
Structural elements near the C-terminus are responsible for changes in nicotinic receptor gating kinetics following patch excision. J Physiol (2000) 1.09
End-plate acetylcholine receptor: structure, mechanism, pharmacology, and disease. Physiol Rev (2012) 1.06
Acetylcholine receptor delta subunit mutations underlie a fast-channel myasthenic syndrome and arthrogryposis multiplex congenita. J Clin Invest (2001) 1.02
hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome. Hum Mol Genet (2008) 1.00
Mutation causing congenital myasthenia reveals acetylcholine receptor beta/delta subunit interaction essential for assembly. J Clin Invest (1999) 0.99
Engineering a prokaryotic Cys-loop receptor with a third functional domain. J Biol Chem (2011) 0.94
Agonist-dependent single channel current and gating in alpha4beta2delta and alpha1beta2gamma2S GABAA receptors. J Gen Physiol (2008) 0.92
Molecular dissection of Cl--selective Cys-loop receptor points to components that are dispensable or essential for channel activity. J Biol Chem (2011) 0.87
The alpha 1 and alpha 6 subunit subtypes of the mammalian GABA(A) receptor confer distinct channel gating kinetics. J Physiol (2004) 0.84
How to force conformity on transmitter-gated channels. J Gen Physiol (2000) 0.78
A single mutation in the acetylcholine receptor δ-subunit causes distinct effects in two types of neuromuscular synapses. J Neurosci (2014) 0.77
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med (2001) 16.81
Data transformations for improved display and fitting of single-channel dwell time histograms. Biophys J (1987) 9.64
Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science (1997) 6.66
Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science (1997) 4.55
Activation of acetylcholine receptors on clonal mammalian BC3H-1 cells by low concentrations of agonist. J Physiol (1986) 3.76
Plant paralog to viral movement protein that potentiates transport of mRNA into the phloem. Science (1999) 3.51
Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med (1989) 3.32
Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology (1975) 2.89
Highly sensitive biological and chemical sensors based on reversible fluorescence quenching in a conjugated polymer. Proc Natl Acad Sci U S A (1999) 2.85
Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model. Proc Natl Acad Sci U S A (1995) 2.83
Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann Neurol (1994) 2.82
Agonists block currents through acetylcholine receptor channels. Biophys J (1984) 2.81
Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol (1984) 2.66
Activation of a nicotinic acetylcholine receptor. Biophys J (1984) 2.57
Correlating phenotype and genotype in the periodic paralyses. Neurology (2004) 2.55
Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron (1995) 2.55
Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell (1991) 2.48
The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J Biol Chem (1999) 2.45
Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol (1990) 2.42
Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome. Science (1973) 2.34
Fingerprint body myopathy, a newly recognized congenital muscle disease. Mayo Clin Proc (1972) 2.34
Peroxisome targeting signal of rat liver acyl-coenzyme A oxidase resides at the carboxy terminus. Mol Cell Biol (1989) 2.33
Nanoscale nuclear magnetic resonance with a nitrogen-vacancy spin sensor. Science (2013) 2.33
Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit. Neuron (1996) 2.27
Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. J Gen Physiol (1997) 2.25
The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain (2005) 2.17
Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell (1994) 2.15
The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med (1990) 2.06
Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve (1981) 2.06
Relationship between reversible antagonist occupancy and the functional capacity of the acetylcholine receptor. J Biol Chem (1981) 2.05
The relationship between agonist occupation and the permeability response of the cholinergic receptor revealed by bound cobra alpha-toxin. J Biol Chem (1980) 2.02
Polymyositis mediated by T lymphocytes that express the gamma/delta receptor. N Engl J Med (1991) 2.00
Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve (1983) 1.99
Mitochondrial mutation in fatal infantile cardiomyopathy. Lancet (1990) 1.98
Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit. Proc Natl Acad Sci U S A (1995) 1.92
Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain (2007) 1.91
Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci U S A (2001) 1.90
Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology (1989) 1.90
Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol (1989) 1.89
Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme. Proc Natl Acad Sci U S A (1998) 1.85
Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin Proc (1977) 1.85
The immunobiology of muscle. Immunol Today (1994) 1.83
Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci U S A (1989) 1.82
Inclusion body myositis. Observations in 40 patients. Brain (1989) 1.82
[The fecal flora of man. IV. Communication: Comparison of the newly developed method with the old conventional method for the analysis of intestinal flora (author's transl)]. Zentralbl Bakteriol Orig A (1976) 1.79
Acetylcholinesterase of human erythrocytes and neuromuscular junctions: homologies revealed by monoclonal antibodies. Proc Natl Acad Sci U S A (1982) 1.79
Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model. Neurology (1977) 1.78
AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis. Neurology (2000) 1.77
Myasthenia gravis and myasthenic syndromes. Ann Neurol (1984) 1.77
Anti-MuSK autoantibodies block binding of collagen Q to MuSK. Neurology (2011) 1.77
Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita. Neuron (1992) 1.75
The extracellular linker of muscle acetylcholine receptor channels is a gating control element. J Gen Physiol (2000) 1.74
Structural basis of the different gating kinetics of fetal and adult acetylcholine receptors. Neuron (1994) 1.72
Acid maltase deficiency in adults: studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies. Brain (1970) 1.72
The spectrum and diagnosis of acid maltase deficiency. Neurology (1973) 1.71
Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl Acad Sci U S A (1983) 1.71
Patients with idiopathic cardiomyopathy belong to the same mitochondrial DNA gene family of Parkinson's disease and mitochondrial encephalomyopathy. Biochem Biophys Res Commun (1991) 1.70
Myotonic dystrophy with no trinucleotide repeat expansion. Ann Neurol (1994) 1.68
Serum choline activates mutant acetylcholine receptors that cause slow channel congenital myasthenic syndromes. Proc Natl Acad Sci U S A (1999) 1.68
Seronegative Lambert-Eaton myasthenic syndrome: study of 110 Japanese patients. Neurology (2002) 1.67
The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment. Brain (2009) 1.65
Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology (1978) 1.63
Long-term follow-up of the Ischemic Heart Disease Life Stress Monitoring Program. Psychosom Med (1989) 1.63
Leucine incorporation into mixed skeletal muscle protein in humans. Am J Physiol (1988) 1.62
Histometric analysis of the ultrastructure of the neuromuscular junction in myasthenia gravis and in the myasthenic syndrome. Ann N Y Acad Sci (1971) 1.62
New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet (1996) 1.60
Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. Ann Neurol (1996) 1.60
Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit. J Neurosci (1997) 1.59
Acetylcholine receptor activation by a site-selective ligand: nature of brief open and closed states in BC3H-1 cells. J Physiol (1986) 1.59
Niemann-Pick C1 disease: the I1061T substitution is a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype. Am J Hum Genet (1999) 1.57
Acid protease production by fungi used in soybean food fermentation. Appl Microbiol (1974) 1.56
Exercise effects on bone mass in postmenopausal women are site-specific and load-dependent. J Bone Miner Res (1996) 1.56
Multicore disease. A recently recognized congenital myopathy associated with multifocal degeneration of muscle fibers. Mayo Clin Proc (1971) 1.56
dE2F2, a novel E2F-family transcription factor in Drosophila melanogaster. Biochem Biophys Res Commun (1998) 1.54
Antibacterial activity produced by molds commonly used in oriental food fermentations. Mycologia (1972) 1.54
Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies. J Exp Med (1976) 1.53
Failure of inactivation of Duchenne dystrophy X-chromosome in one of female identical twins. Neurology (1977) 1.53
Improving adherence to dementia guidelines through education and opinion leaders. A randomized, controlled trial. Ann Intern Med (1999) 1.53
Association between oral malodor and adult periodontitis: a review. J Clin Periodontol (2001) 1.53
A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel. Ann Neurol (1982) 1.52
Congenital myasthenic syndrome caused by a mutation in the Ets-binding site of the promoter region of the acetylcholine receptor epsilon subunit gene. Neuromuscul Disord (1999) 1.52
Collagen membranes: a review. J Periodontol (2001) 1.52